Tata Chemicals Ltd. reported a consolidated net loss of ₹49 crore for Q4FY25, significantly lower than the ₹841 crore loss in Q4FY24, reflecting a 94% YoY improvement in bottom line. Revenue from operations for the March quarter stood at ₹3,509 crore, marginally up from ₹3,475 crore last year.
For the full year ended March 31, 2025, the company posted revenue of ₹14,887 crore, compared to ₹15,421 crore in FY24. The net profit for FY25 was ₹387 crore, down from ₹435 crore in the previous year.
Dividend Declaration
The Board of Directors has recommended a final dividend of ₹11 per share (110% of the face value) for FY2024-25. If approved by shareholders at the company’s 86th Annual General Meeting (AGM), the dividend will be paid (subject to TDS) within five days of the AGM.
Fund Raising Plan
The Board has also approved a proposal to raise up to ₹200 crore via term loans and/or issuance of Non-Convertible Debentures (NCDs) on a private placement basis. An internal committee has been authorised to oversee the finalisation of terms and allotment of the NCDs.
